{"nct_id":"NCT05382312","title":"Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary Tuberculosis","status":"COMPLETED","status_verified_date":"2025-09","start_date":"2022-07-26","start_date_type":"ACTUAL","primary_completion_date":"2025-05-27","primary_completion_date_type":"ACTUAL","completion_date":"2025-05-27","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}